The cellular prion protein PrP C confers susceptibility to transmissible spongiform encephalopathies, yet its normal function is unknown. Although PrP C -deficient mice develop and live normally, expression of amino proximally truncated PrP C (⌬PrP) or of its structural homolog Doppel (Dpl) causes cerebellar degeneration that is prevented by coexpression of full-length PrP C . We now report that mice expressing ⌬PrP or Dpl suffer from widespread leukoencephalopathy. Oligodendrocyte-specific expression of full-length PrP C under control of the myelin basic protein (MBP) promoter repressed leukoencephalopathy and vastly extended survival but did not prevent cerebellar granule cell (CGC) degeneration. Conversely, neuron-specific PrP C expression under control of the neuron-specific enolase (NSE) promoter antagonized CGC degeneration but not leukoencephalopathy. PrP C was found in purified myelin and in cultured oligodendrocytes of both wild-type and MBP-PrP transgenic mice but not in NSE-PrP mice. These results identify white-matter damage as an extraneuronal PrP-associated pathology and suggest a previously unrecognized role of PrP C in myelin maintenance.
Introduction
The infectious agent causing transmissible spongiform encephalopathies (TSE) was termed prion (Prusiner, 1982) . Its only known constituent is PrP Sc , a TSE-associated isoform of the cellular prion protein PrP C . Ablation of the Prnp gene, which encodes PrP C , abrogates prion replication (Büeler et al., 1993 ) and scrapie pathogenesis , but the physiological function of PrP C has remained elusive (Aguzzi and Polymenidou, 2004) . Prnp o/o mice show no obvious developmental defects and enjoy a normal life expectancy (Büeler et al., 1992) . Subtle changes in circadian rhythms (Tobler et al., 1996) , alterations of hippocampal function (Collinge et al., 1994; Colling et al., 1997; Herms et al., 1999; Mallucci et al., 2002) , and behavioral abnormalities have been described. However, some of these phenotypes were not reproduced by others (Lledo et al., 1996) , and none were clarified in molecular terms. PrP C binds copper (Brown et al., 1997; Kretzschmar et al., 2000) and may have antiapoptotic properties (Kuwahara et al., 1999; Bounhar et al., 2001; Chiarini et al., 2002; Zanata et al., 2002) but could also sensitize neurons to apoptotic stimuli (Paitel et al., 2003) . A possible dismutase activity of PrP C was not confirmed in vivo (Waggoner et al., 2000; Hutter et al., 2003) . Several factors bind PrP C , including the laminin receptor precursor protein (Rieger et al., 1997) , heparan sulfate (Caughey et al., 1994) , neural cell adhesion molecule (NCAM) (Schmitt-Ulms et al., 2001) , and bcl-2 ( Kurschner et al., 1995) . However, none of these interactions were shown to be functionally significant. Hence, no unified view of PrP C function has emerged from the above observations. Transgenic expression of amino proximally truncated PrP C mutants causes early-onset ataxia associated with progressive cerebellar granule cell (CGC) degeneration and death at 3-4 months of age, also referred to as Shmerling's syndrome (Shmerling et al., 1998) . Only truncated versions of PrP C encompassing half (amino acids ⌬34 -121) or all (amino acids ⌬34 -134) of the highly conserved hydrophobic transmembrane domain 1 (TM1) region (amino acids 113-134) (collectively termed ⌬PrP) induce disease. A similar neurodegenerative phenotype affecting cerebellar Purkinje cells was observed in compound heterozygous Prnp o/ZHII mice and in homozygous Prnp ZHII/ZHII mice (Rossi et al., 2001) , whose targeted Prnp ZHII allele (termed "ZHII" because it was the second targeting event of Prnp executed in Zurich) leads to overexpression of the PrP C homolog Doppel (Dpl) (Weissmann and Aguzzi, 1999) . This phenotype is only observed in Prnp o/o mice that overexpress ⌬PrP or Dpl and is fully reverted by substoichiometric coexpression of full-length PrP C , as either the original endogenous Prnp locus or a transgene under transcriptional control of a "half-genomic" miniversion of Prnp . It follows that ⌬PrP and Dpl interfere with a physiological function of PrP C .
Here we show that, in addition to CGC degeneration, mice expressing ⌬PrP or Dpl in their brain suffer from widespread cerebellar leukoencephalopathy. Oligodendrocyte-specific expression of PrP C repressed this pathology and restored long-term survival but did not rescue CGC death. Conversely, neuronspecific expression of PrP C delayed disease onset and antagonized, to some extent, CGC degeneration but did not prevent white-matter degeneration. Therefore, white-matter disease and CGC degeneration are independent of each other. Surprisingly, white-matter disease appears to represent a major survivallimiting pathology induced by a toxic PrP mutant.
Materials and Methods
Generation of myelin basic protein-PrP and neuron-specific enolase-PrP transgenic mice. Mice hemizygously transgenic for the ϩ/Ϫ allele (Shmerling et al., 1998) and hemizygous for the ablated endogenous Prnp locus (Prnp ϩ/ZHI ) (Büeler et al., 1992) mice (Rossi et al., 2001 ). The wild-type and neo-targeted Prnp loci were detected by PCR analysis of tail DNA as described previously (Büeler et al., 1992) , the F35(PrP⌬32-134) transgene was detected as described previously (Shmerling et al., 1998) , and the ZHII-lox1 locus was also detected as described previously (Rossi et al., 2001) . To detect the MBP-PrP transgene, the following primers were used: 5Ј-ggc aac gtg ctg gtt att gtg c-3Ј and 5Ј-tcc cca gca tgt agc cac caa gg-3Ј (annealing at 58°C animals. Primers used were as follows: Prnpint2, 5Ј-ATA CTG GGC ACT GAT ACC TTG TTC CTCA T; P10rev, 5Ј-GCT GGG CTT GTT CCA CTG ATT ATG GGT AC. These primers amplify selectively the wild-type Prnp allele but not the NSE-PrP transgene and were used to identify animals negative for wild-type Prnp. Standard PCR for Prnp (Büeler et al., 1992) detected both the NSE-PrP and the wild-type Prnp allele and was used to confirm the inheritance of the NSE-PrP in animals lacking wild-type Prnp. Onset of disease was declared when animals exhibited unambiguous tremor or unsteady gait that was blindly recognizable from healthy littermates in the same cage by two different observers. Animals were considered to be at a terminal disease stage when they developed hindlimb paralysis and were unable to reposition for 10 s after having been turned back-down. Histopathology. Organs were fixed in 4% paraformaldehyde (PFA) in PBS, pH 7.5, paraffin embedded, and cut into 2 m sections. Brain sections were stained with hematoxylin-eosin, Luxol-Nissl (myelin and neurons), and commercial antibodies to GFAP (Dako, Carpinteria, CA), microtubule-associated protein-2 (MAP-2) (Chemicon, Temecula, CA), CNPase (Roche, Basel, Switzerland), or phosphorylated neurofilament protein (Sigma, St. Louis, MO). For major histocompatibility complex class II (MHC-II) and CD11b stains, tissues were snap frozen in OCT, cut on a vibratome, and stained with antibodies to CD11b (PharMingen, San Diego, CA) or MHC-II (Serotec, Oxford, UK). Antibody stainings were visualized using the peroxidase-anti-peroxidase method or a fluorescent secondary antibody. Apoptosis was assessed using the in situ cell death kit (Roche) according to the instructions of the manufacturer.
Semithin sections and electron microscopy. Mice were perfused with ice-cold 4% PFA/3% glutaraldehyde. Brains and spinal cord were removed, immersed in the same solutions, and kept at 4°C until processing. Tissues were embedded in Epon, and semithin sections were stained with toluidine blue or used for electron microscopy.
Myelin preparation. Myelin was purified from mouse brains as described previously (Norton and Poduslo, 1973) . Brain homogenates (5% w/v) were prepared in 0.32 M sucrose. An aliquot of the homogenate was stored at Ϫ80°C. The rest was layered over 0.85 M sucrose and centrifuged at 75,000 ϫ g for 30 min. Crude myelin was collected from the interface, resuspended in water, and centrifuged at 75,000 ϫ g for 15 min. The resultant pellet was osmotically shocked in deionized water to remove contaminants from within myelin vesicles and centrifuged twice at 12,000 ϫ g for 15 min. The pellets were resuspended in 0.32 M sucrose, layered over 0.85 M sucrose, and centrifuged at 75,000 ϫ g for 30 min. Myelin was again collected from the interface, resuspended in deionized water, and pelleted at 75,000 ϫ g for 15 min to remove residual sucrose. Finally, myelin was resuspended in water and stored at Ϫ80°C. Equal amounts of myelin preparation were then processed for immunoblotting using an anti-PrP antibody [ICSM-18 (White et al., 2003) or POM-1 (M. Polymenidou and A. Aquzzi, unpublished observation)], an anti-NCAM antibody (Research Diagnostics, Flanders, NJ), or an anti-GFAP antibody (Dako, Glostrup, Denmark) .
Oligodendrocyte cultures. Mixed glial cell cultures containing oligodendrocytes and astrocytes were produced from 1-d-old neonatal mice as described previously (McCarthy and de Vellis, 1980; Trotter and Schachner, 1989) . Cultures were prepared with high-glucose DMEM supplemented with 10% fetal bovine serum and replenished on day 4 and every 3-4 d thereafter for 10 d with DMEM plus 10% heat-inactivated horse serum. Oligodendrocytes were purified from mixed glial cultures by differential detachment and negative selection of microglia by adherence to hydrophobic plastic. Purified oligodendrocytes were then plated onto glass or plastic culture chambers coated, respectively, with 100 or 10 g/ml poly-L-lysine. Oligodendrocyte precursors were expanded with PDGF-and FGF-supplemented SATO medium [400 ng/ml T3, 400 ng/ml T4, 2 mmol/L glutamine, 50 U/ml penicillin, 50 g/ml streptomycin, and 5 ml of N2 supplement (Invitrogen, Paisley, UK)] for 2 d and subsequently differentiated with 1% horse serum-supplemented SATO medium. After 3 d of differentiation, cells were washed with PBS and homogenized in PBS containing 0.5% NP-40, 0.5% sodium deoxycholate, and protease inhibitors (Roche). Homogenate was then incubated on ice for 30 min and centrifuged at 10,000 rpm for 15 min at 4°C. Equal amounts of lysate were then processed for immunoblotting with a mouse monoclonal antibody to PrP (ICSM-18) (White et al., 2003) and with a mouse monoclonal anti-actin antibody (Chemicon).
Flotation assays. Flotation of detergent-insoluble complexes was performed as described previously (Naslavsky et al., 1997) . Appropriate brain homogenates were extracted for 1 h on ice in cold lysis buffer (150 mM NaCl, 25 mM Tris-HCl, pH 7.5, 5 mM EDTA, and 1% Triton X-100; total protein, 30 g in 100 l). Extracts were mixed with two volumes (200 l) of 60% Optiprep (Axis Shield, Oslo, Norway) to reach a final concentration of 40%. All lysates were loaded at the bottom of Beckman Instruments (Fullerton, CA) ultracentrifuge tubes. A 5-30% Optiprep step gradient in TNE (in mM: 150 NaCl, 25 Tris-HCL, pH 7.5, and 5 EDTA) was then overlaid onto the lysate (1300 l of 30% Optiprep and 300 l of 5% Optiprep). Tubes were centrifuged for 12 h at 4°C in a TLS55 Beckman Instruments rotor at 100,000 ϫ g. Fractions (200 l) were collected from the top of the tube and processed for immunoblotting and visualization with an anti-PrP antibody [ICSM-18 (White et al., 2003) or POM-1 (Polymenidou and Aquzzi, unpublished observation); both detect the PrP core and display identical patterns] and an antiflotillin 1 antibody (BD Transduction Laboratories, Lexington, KY).
Western blot analysis of myelin proteins. Brains and spinal cords were removed and homogenized in lysis buffer containing 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM sodium orthovanadate (Fluka, Basel, Switzerland), and protease inhibitors (Roche) in PBS. Homogenates were incubated on ice for 30 min and centrifuged at 10,000 rpm for 10 min at 4°C. Equal amounts of lysate (10 g of protein for spinal cord and 20 g of protein for brain homogenate) were separated by electrophoresis on 12% SDS-PAGE gels and transferred to nitrocellulose membranes. The membranes were probed with antibodies to MBP (Chemicon), myelin-associated glycoprotein (MAG) (Chemicon), proteolipid protein (PLP) (Chemicon), 2Ј,3Ј-cyclic nucleotide 3Ј-phosphodiesterase (CNP) (Abcam, Cambridge, UK), and actin (Chemicon). The amount of MBP, MAG, and actin was quantified using a VersaDoc model 4000 Imaging System (Bio-Rad, Zurich, Switzerland).
Northern blots. Brains were collected and immediately snap frozen in liquid nitrogen before storage at Ϫ80°C until required. Total RNA was isolated using Trizol (Invitrogen, Basel, Switzerland) with a T18 Basic Disperser (Ika Works, Staufen, Germany). Northern blot hybridization experiments were performed according to standard procedures (Sambrook and Russell, 2001) using 15 g of total RNA. Random primed [␣-
32 P]deoxyCTP probes were prepared from 20 ng of gel-purified DNA homologous to target transcripts using a Rediprime II random priming kit (Amersham Biosciences, Otelfingen, Switzerland) and purified with Nick Sephadex G50 columns (Amersham Biosciences). Prehybridization and hybridization were performed overnight at 42°C using Ultrahyb (Ambion, Austin, TX), containing 1 ϫ 10 6 cpm/ml radiolabeled probe, 100 g/ml denatured herring sperm DNA (Catalysis), and 20 g/ml denatured yeast tRNA (Fluka). Posthybridization washes were performed according to Ultrahyb instructions. Hybridization signals were quantified using Fujifilm (Tokyo, Japan) imaging plate technology (BAS-1800II) and normalized for variations in RNA loading by subsequent probing with an excess of 18S ribosomal RNA cDNA probe (Miele et al., 1998) .
Results

Myelinopathy and axonal degeneration in ⌬PrP
o mice Hemizygous hg-PrP⌬ tg/Ϫ transgenic mice, which express amino proximally truncated PrP C under transcriptional control of a half-genomic Prnp minigene (henceforth termed ⌬PrP ϩ mice) were bred to Prnp o/o mice. The resulting mice (termed ⌬PrP o ), hemizygous for the hg-PrP⌬(32-134) transgene and devoid of both endogenous Prnp alleles, developed CGC degeneration as described previously (Shmerling et al., 1998) (Fig. 1a,b ). In addition, histological analysis of terminally sick ⌬PrP o brains revealed additional coarse vacuolar degeneration of the intrapontine part of cranial nerves (Fig. 1d,e) . Also, substantial areas of white matter in the cerebellum, the brainstem, as well as the anterior and lateral spinal cord columns exhibited large vacuoles, astrogliosis, and activated microglia/ macrophages ( Fig. 1m-r) .
We also bred heterozygous and homozygous hg-PrP⌬(32-121) tg transgenic mice, which express a Prnp version with a smaller deletion than the hg-PrP⌬(32-134) transgene, to the Prnp o/o genetic background. We found that both the hgPrP⌬(32-121) and hg-PrP⌬(32-134) transgenes induced analogous white-matter lesions in Prnp o/o mice (data not shown). Therefore, in all experiments described below, we used ⌬PrP o mice as a general paradigm for the toxicity of amino proximally truncated PrP C . Myelinated fibers in spinal cord and cerebellar white matter displayed severe axonal loss associated with large vacuoles and degeneration of myelin sheaths into condensed spheroids (Fig.  2a-f ) . Semithin sections and electron microscopy did not evidence any abnormality in myelin thickness, spacing, and periodicity in ⌬PrP o and ⌬PrP ϩ mice (Fig. 2i ), but many individual sheaths displayed vacuoles, especially around large axons. Axonal pathology was evident in the latter areas. Some axons were swollen and featured accumulation of mitochondria and dense bodies (Fig. 2j,k) . Other axons suffered from compromised adhesion to their myelin sheaths, evident as periaxonal splitting over broad portions of the axolemma and detachment from the myelin wrap (Fig. 2l,m) . Many axons had completely degenerated, leaving behind empty myelin rings or collapsed and condensed residual myelin ghosts (Fig. 2n,o) .
Axon-myelin pathology may result from developmental myelination failure or, alternatively, from degeneration of myelinated axons after completion of normal development. This question was addressed by studying semithin spinal cord and cerebellar white-matter sections from postnatal day 25 mice, . m-r, Astrogliosis and microglia activation in the white matter of ⌬PrP o but not of ⌬PrP ϩ mice. Astrocytes were visualized with antibodies to GFAP (m, n), whereas activated microglia and macrophages were stained with antibodies to CD11b (o, p) and MHC-II (q, r).
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• Prion Protein and Doppel in the Absence of PrP C shortly after completion of the myelination process. We found no vacuolation, hypomyelination, or axonal loss at this early stage (Fig. 2g,h ), suggesting that pathological changes occur after myelination and are of degenerative rather than developmental origin.
Although florid apoptosis was only found in CGCs, as described previously (Shmerling et al., 1998) , abnormal accumulations of perikaryal phosphorylated neurofilament proteins were visible in degenerating CGCs, as well as in brainstem and spinal cord neurons (Fig. 3) , implying that neurons other than CGCs may also be affected by ⌬PrP toxicity. Additionally, this suggests that axonal damage and pathologic cytoplasmic accumulation of phosphorylated neurofilament are a primary consequence of ⌬PrP expression rather than secondary to neuronal cell death. We considered whether axon-myelin degeneration might result from oligodendroglial damage. However, no apoptosis was found in the white matter of diseased animals (Fig. 3) , suggesting that oligodendrocyte survival was not generally impaired by ⌬PrP. Therefore, general oligodendroglial cytotoxicity is unlikely to account for white-matter pathology.
White-matter pathology in Prnp
o/o mice overexpressing Dpl The prion protein homolog Dpl bears structural resemblance to ⌬PrP (Luhrs et al., 2003) and is encoded by the Prnd gene, which is situated 16 kb 3Ј of Prnp. In homozygous Prnp ZHII/ZHII and in compound heterozygous Prnp ZHII/o mice, loxP-mediated deletion of the entire third Prnp exon induces atypical intergenic splicing patterns that place Dpl under transcriptional control of the Prnp promoter, thereby leading to Dpl overexpression in brain (Weissmann and Aguzzi, 1999; Rossi et al., 2001 ). Overexpression of Prnd leads to cerebellar degeneration, possibly by similar mechanisms as ⌬PrP (Moore et al., 1999; Genoud et al., 2004) . We therefore analyzed the white matter of 18-month-old Prnp ZHII/o mice with advanced clinical disease. We found whitematter vacuolation similar to that of ⌬PrP o mice (Fig. 1c,f,i) . Unexpectedly, white-matter disease was not restricted to cerebellum, brainstem, and spinal cord, but extended into the forebrain white matter, the pyramidal projections, and the corpus callosum ( Fig. 1j-l ) .
Oligodendroglial PrP
C represses leukoencephalopathy but not granule cell degeneration Axons and their myelin sheaths are functionally dependent on each other: degeneration in one compartment may result in secondary damage to the other compartment. Alternatively, damage may result from parallel primary toxicity to both compartments. If myelin-producing oligodendrocytes were a primary target of mutant PrP C and Dpl, selective oligodendrocytic expression of PrP C should repress white-matter pathology. We therefore crossed ⌬PrP o mice to tg640 mice, which express full-length PrP C under transcriptional control of a myelin basic protein promoter fragment (Fig. 4a) (Prinz et al., 2004) .
Hemizygous expression of the MBP-PrP transgene significantly delayed the onset of tremor and ataxia (mean time of onset, 74 Ϯ 3 vs 43 Ϯ 2 d; p Ͻ 0.0001) ( Table 1, Fig. 4a,c) ⌬PrP°mice. The weight of 1-year-old ⌬PrP o MBP-PrP tg/Ϫ was still 17-19 g. Remarkably, these mice achieved long-term survival (Ͼ400 d), with stable or minimally progressing disease, whereas the mean survival time of ⌬PrP o littermates was 99 Ϯ 5.3 d (Fig.  4a,c) . Histological analysis showed repression, but not complete rescue, of axon-myelin degeneration and white-matter vacuolation ( Fig. 4g-j) . Instead, no rescue of CGC was observed (Fig.  4e,f ) , confirming that white-matter disease is unrelated to CGC degeneration. These results strengthen the conjecture that myelin is a direct target of ⌬PrP toxicity.
Compound heterozygous Prnp ZHII/ZHI mice develop neurological symptoms at 13-21 months and survive 18 -24 months (Rossi et al., 2001) . Also in these mice, intercross with tg640 mice delayed onset of disease, prolonged survival (Table 1, Fig. 4b,d) , and repressed axon-myelin degeneration (Fig. 4m-p) , adding support to the hypothesis that Dpl and ⌬PrP share the same pathological basis. However, expression of the MBP-PrP transgene did not rescue Purkinje cell degeneration (Fig. 4k,l ) .
Neuronal PrP
C expression antagonizes CGC degeneration but does not prevent leukoencephalopathy Neuronal processes may conceivably represent the primary target of mutant PrP toxicity, whereas myelinopathy may be secondary to axonal degeneration. If so, oligodendrocytes may provide PrP C to the axon-myelin interface, which would abrogate any cell-autonomous axonal ⌬PrP toxicity in trans. Intercellular transfer of glycosylphosphatidylinositol (GPI)-anchored protein (a phenomenon called "cell painting") was described for CD4 (Anderson et al., 1996) and for PrP C in vitro (Liu et al., 2002) . Alternatively, PrP C may act as a ligand and trigger signaling through receptors expressed by neighboring cells.
These scenarios were tested by crossing ⌬PrP o mice with mice (Fig. 5a) Fig. 5b) . However, histological analysis of clinically sick animals revealed leukoencephalopathy of similar severity in ⌬PrP o and ⌬PrP o NSE-PrP mice but not in age-matched ⌬PrP ϩ animals ( Fig. 5c-h) . Leukoencephalopathy was found also in pyramidal tracts, corpus callosum, and optic tracts (data not shown), suggesting that neuronal protection, by prolonging survival, allowed for more extensive development of myelin pathology.
These findings indicate that neuron-restricted expression, even at supraphysiological levels, does not suffice to prevent ⌬PrP-induced leukoencephalopathy and adds strength to the contention that ⌬PrP o leukoencephalopathy is a primary myelin pathology. ⌬PrP o NSE-PrP mice suffered also from CGC degeneration, although to a lesser extent than ⌬PrP o mice. This sug- Significance p values were derived by comparing mean survival or disease onset times of transgenic and control mice (unpaired Student's t test).
gests that neuron-restricted expression of PrP C is beneficial but insufficient to completely prevent neuronal death (Fig. 5c,d ) and raises the possibility that CGC may suffer (at least in part) from deafferentation after degeneration of white-matter fibers innervating the granule cell layer. (Fig. 6a) . However, we found PrP C also in purified myelin of NSE-PrP mice, whose oligodendrocytes do not express PrP C (Fig. 6a,d ). Poor fractionation with neuronal or astrocytic components contaminating the myelin preparations appears to be very unlikely, because GFAP and NCAM, which would be indicative of contamination, were essentially removed (Fig. 6b,c) . The 120 kDa isoform of NCAM is the major isoform found in oligodendrocytes and myelin sheaths (Bhat and Silberberg, 1988) . Intriguingly, ⌬PrP brain homogenates displayed prominent NCAM 180, as well as two additional NCAM bands of unknown origin, which will be characterized in future studies. The presence of PrP C in myelin of NSE-PrP mice, therefore, suggests that axolemmal PrP undergoes high-affinity interactions with myelin membrane proteins, as shown for other proteins of the myelin-axolemmal complex (Menon et al., 2003) . Alternatively, neuronally synthesized PrP C may be transferred onto myelin sheaths by cell painting, which was shown to be highly efficient in the case of GPI-linked proteins (Anderson et al., 1996) .
PrP
Unglycosylated PrP C seems to be predominant in myelinic PrP C (Fig. 6a) , similarly to what was observed in MBP-PrP mice (Prinz et al., 2004) . The intense low-molecular-weight PrP C bands in MBP-PrP mice might reflect degradation of unglycosylated PrP C , because glycosylation is known to influence the stability of proteins.
⌬PrP and PrP C in MBP-PrP mice are localized in lipid rafts PrP C localizes to lipid rafts (Naslavsky et al., 1997; Meier et al., 2003) , in which it may exert a physiological function by interacting with signaling molecules. Dpl is also found in rafts (Massimino et al., 2004) . If toxicity of ⌬PrP and Dpl results from interference with some PrP Cmediated signaling pathway and toxicity is counteracted by PrP C , these three proteins may compete for the same partners on rafts. Moreover, ⌬PrP and Dpl may disrupt normal axon-glia interaction and adhesion, whose integrity depends on GPIanchored and transmembrane proteins (Falk et al., 2002; Marcus et al., 2002; Bartsch, 2003; Vinson et al., 2003) . To investigate the topology of ⌬PrP, we performed flotation assays on Optiprep gradients with cold Triton X-100-treated ⌬PrP o brain extracts. ⌬PrP was detected in lowdensity, detergent-insoluble fractions and displayed buoyancy similar to that of PrP and flotillin (Fig. 6f-j) . These characteristics strongly suggest that ⌬PrP is indeed localized in lipid rafts and colocalized with wild-type PrP C . Therefore, cytotoxicity is unlikely to be attributable to inappropriate membrane targeting of ⌬PrP. In addition, PrP C from MBP-PrP mice associated with rafts similarly to PrP C from wild-type mice (Fig. 6i) . Unglycosylated PrP C was the dominant moiety, similar to PrP C isolated from myelin.
Neither ⌬PrP nor Dpl affect myelin protein expression Leukoencephalopathy in ⌬PrP o and Prnp ZHII/o mice had features suggestive of compromised axon-glial adhesion similar to those described in mice lacking MAG and myelin galactolipids (Marcus et al., 2002) , as well as in mice deficient for PLP (Griffiths et al., 1998) . In addition, we found axonal swellings similar to those of Cnp1 Ϫ/Ϫ mice (Lappe-Siefke et al., 2003) . Moreover, in mice deficient for these diverse myelin proteins, oligodendrocytes produce appropriately thick myelin sheaths. These findings raised the question as to whether ⌬PrP and Dpl might affect the synthesis or the stability of the above myelin components. Therefore, we analyzed the myelin content in whole brain and spinal cord homogenates of Prnp o/o , Prnp ϩ/ϩ , ⌬PrP o , and Prnp ZHII/o mice (age, 2 months). MAG, MBP, PLP, and CNP transcription and protein content were assayed with Northern and Western blots (Fig. 7a,b) . The amount of MAG and MBP protein was normalized against actin (Fig. 7c) . These analyses revealed that both the transcription and the steady-state protein concentration of all investigated myelin proteins were unchanged in ⌬PrP o and Prnp ZHII/o mice.
Discussion
Overexpression of amino proximally truncated PrP C variants collectively termed ⌬PrP, (Shmerling et al., 1998) , or of the structural PrP C homolog Dpl (Weissmann and Aguzzi, 1999; Behrens , 2002) , triggers neuronal degeneration. We now report that both ⌬PrP and Dpl elicit additional leukoencephalopathy. These pathologies were not entirely expected, because PrP-related diseases are thought to affect primarily neurons (Chiesa et al., 1998 (Chiesa et al., , 2000 Hegde et al., 1998 Hegde et al., , 1999 Shmerling et al., 1998; Rossi et al., 2001 ). Conversely, myelin sheath damage and neuroaxonal dystrophy (Liberski et al., 2002) , as well as cytopathic changes in oligodendrocytes (El Hachimi et al., 1998) , have been noted in human and animal TSEs. Myelinopathy, rather than neuronal damage, may be a major determinant of lethality in Shmerling's syndrome, because oligodendrocyte-restricted expression of PrP C selectively suppresses leukoencephalopathy and restores long-term survival. Instead, neuron-restricted expression of PrP C , even at supraphysiological levels, does not prevent white-matter degeneration. These data indicate that leukoencephalopathy is not just a consequence of neurodegeneration but suggest a primary role of oligodendrocytes in white-matter disease. Oligodendrocyte-restricted PrP C may repress in trans the axonal pathology elicited by mutant PrP. A cellular signal might be transduced through PrP C from oligodendrocytes to axons, analogously to other GPIanchored proteins (such as F3 and NCAM 120) that play a role in axon-myelin interactions (Falk et al., 2002) . Because PrP C binds in vitro to the transmembrane and GPI-linked forms of NCAM (Schmitt-Ulms et al., 2001) , it might contribute to the very same pathways. Alternatively, PrP C may instruct oligodendrocytes to release factors necessary for axonal survival (Wilkins et al., 2003) . Direct toxicity of ⌬PrP and Dpl to oligodendrocytes seems to be unlikely, because we did not observe oligodendrocytic cell death or ultrastructural abnormalities in oligodendrocytes. Both oligodendrocyte-and neuron-restricted expression delayed the clinical course of Shmerling's disease, yet only endogenous PrP C expression, which occurs on both neurons and glia (Moser et al., 1995) , brought about complete rescue. Therefore, both neuronal and oligodendrocyte PrP C expression are needed for maintenance of the axon-myelin interface in ⌬PrP mice.
Surprisingly, neuron-specific PrP C expression, even at supraphysiological levels, did not completely rescue CGC degeneration. Perhaps ongoing degeneration of white-matter fibers innervating the granule cell layer participates indirectly in granule cell degeneration, e.g., by deafferentation and neuronal "dying back." The delayed onset of myelinopathy in ⌬PrP o NSE-PrP mice might be related to the presence of PrP C in NSE-PrP myelin which, in turn, might be attributable to GPI cell painting or to high-affinity interaction of axonal PrP C with myelin components. Leukoencephalopathy in ⌬PrP o and Prnp ZHII/o mice had features suggestive of compromised axon-glial adhesion, including axonal swellings similar to those described in mice lacking MAG and myelin galactolipids (Marcus et al., 2002) , PLP (Griffiths et al., 1998) , and Cnp1 (Lappe-Siefke et al., 2003) . However, expression of MAG, MBP, PLP, and CNP was not affected in ⌬PrP o and Prnp ZHII/o mice, suggesting that disturbance of myelin and axonal physiology is directly mediated by ⌬PrP and Dpl rather than by dysmetabolism of myelin proteins.
The overlapping patterns of (1) Dpl-and ⌬PrP-induced leukoencephalopathy, (2) their modulation by coexpression of fulllength PrP C (Moore et al., 1999; Li et al., 2000; Rossi et al., 2001 ), (3) the structural homology between Dpl and ⌬PrP (Luhrs et al., 2003) , and (4) the abrogation of neurodegeneration by removal of Dpl from Prnp ZHII/ZHII mice (Genoud et al., 2004) all suggest that ⌬PrP and Dpl trigger similar pathogenetic mechanisms. What might be the common structural basis of such pathologies? Of all amino proximal deletions that were tested (Shmerling et al., 1998) , only those that disrupt the highly conserved hydrophobic TM1 region (amino acids 113-134) provoked pathologies that were prevented by wild-type PrP C . Two possible molecular mechanism of toxicity have been put forward. Shmerling et al. (1998) proposed that the amino proximal region of PrP represents an effector domain, whose deletion abolishes trophic signaling and partially reduces the affinity of PrP C for its hypothetical ligands. According to this scenario, removal of the amino proximal confers recessive-negative toxic properties to ⌬PrP that are abolished if ⌬PrP is displaced by PrP C . In wild-type mice, oligodendrocytic PrP C might transduce survival signals by interacting with axonal molecules. Leukoencephalopathy may occur because ⌬PrP abrogates such trophic signals. The absence of such phenotype in Prnp Ϫ/Ϫ mice suggests the existence of a functional homolog provisionally termed (Shmerling et al., 1998) .
Alternatively, PrP C and its homologs may form homo-and hetero-oligomers. Although ⌬PrP and Dpl homo-oligomers may be toxic to neurons, participation of full-length PrP C to such complexes would "dope" their stoichiometry, hence abolishing their toxicity .
It will be interesting to test which of the above hypotheses, if any, reflects the mechanism of ⌬PrP/Dpl-associated damage to the axonmyelin complex. The finding that full-length prion protein, specifically expressed in oligodendrocytes and found in myelin, represses these defects suggests that PrP C plays a role in myelin physiology, oligodendroglial-mediated axonal support, and axon-myelin interactions. This contention is supported by the finding that aged Prnp Ϫ/Ϫ mice suffer from peripheral demyelination. Both leukoencephalopathy and CGC degeneration are suppressed by coexpression of PrP C , suggesting that the molecular pathogenesis of these two diseases is similar.
In addition to its role in prion disease pathogenesis, repression of ⌬PrP/Dplassociated neurodegenerative pathologies is likely to represent the most thoroughly characterized function of PrP C . As shown by the present study, the neurodegenerative syndromes induced by ⌬PrP provide an accessible experimental system for studying function of PrP C in vivo by reverse genetics. 
